Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05060627
Title An Open Label, Multicenter, Phase I/II Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Germans Trias i Pujol (ICO BADALONA) RECRUITING Badalona Spain Details
Hospital Clinic NOT_YET_RECRUITING Barcelona Spain Details
ICO Hospitalet RECRUITING Bellvitge Spain Details
H. Gregorio Marañón NOT_YET_RECRUITING Madrid Spain Details
Hospital Universitario 12 de Octubre NOT_YET_RECRUITING Madrid Spain Details
H. Morales Meseguer RECRUITING Murcia Spain Details
HUCA RECRUITING Oviedo Spain Details
H. Son Llatzer RECRUITING Palma De Mallorca Spain Details
Clínica Universidad de Navarra (CUN) RECRUITING Pamplona Spain Details
Hospital Universitario de Salamanca RECRUITING Salamanca Spain Details
H. Universitario de Canarias NOT_YET_RECRUITING Santa Cruz De Tenerife Spain Details
H. Universitario Marqués de Valdecilla NOT_YET_RECRUITING Santander Spain Details
Complejo Hospitalario Santiago (CHUS) RECRUITING Santiago De Compostela Spain Details
Complejo Hospitalario Virgen del Rocío RECRUITING Sevilla Spain Details
H.U. La Fe RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field